Skip to main content
INNOVA CAPTAB LIMITED logo

INNOVA CAPTAB LIMITED — Investor Relations & Filings

Ticker · INNOVACAP ISIN · INE0DUT01020 LEI · 549300SNL5HFUHE66804 BSE.NS Manufacturing
Open in API
Filings indexed 212 across all filing types
Latest filing 2026-05-26 Board/Management Inform…
Country IN India
Listing BSE.NS INNOVACAP

About INNOVA CAPTAB LIMITED

https://www.innovacaptab.com

Innova Captab Limited is an integrated pharmaceutical company focused on the research, development, manufacturing, and marketing of a wide range of pharmaceutical formulations. The company operates primarily as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services to leading domestic and international pharmaceutical brands. Its product portfolio includes diverse dosage forms such as tablets, capsules, dry syrups, ointments, and injections across multiple therapeutic areas, including anti-infectives, analgesics, and gastrointestinal treatments. Innova Captab maintains a strong emphasis on R&D and quality control, operating advanced manufacturing facilities that adhere to global regulatory standards. In addition to its CDMO business, the company manages a domestic branded generics division and an international export business, catering to a global clientele with a focus on high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
General Updates
Board/Management Information Classification · 85% confidence The document is a stock exchange filing under SEBI listing regulations notifying a change in the composition of the company’s Audit Committee (a board committee). It is not a full report, financial data, or AGM material, but a management/board change announcement. This falls under Board/Management Information (MANG).
2026-05-26 English
Intimation under regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015 - Change in Composition of Committee of the Board
Board/Management Information Classification · 88% confidence The document is an exchange filing under SEBI Listing Obligations Regulation 30 notifying a change in the composition of the Audit Committee (a board-level committee). It announces the addition of a new independent director to the Audit Committee and provides the revised members list. This is a Board/Management Information announcement, not a full report, earnings release, or other category.
2026-05-26 English
General Updates
Board/Management Information Classification · 92% confidence The document is an exchange filing under regulation 30 of SEBI LODR notifying a change in the composition of the company’s Audit Committee (a board committee). It announces the appointment of a new non-executive independent director and the revised committee members. This is an announcement of a board/management change rather than a full report or financial release.
2026-05-26 English
Intimation under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Change in Composition of Audit Committee of the Board
Board/Management Information Classification · 90% confidence The document is an exchange filing under SEBI LODR regulation 30 announcing a change in the composition of the company’s Audit Committee (a board committee). It does not present financial results, audited statements, proxy materials, or dividends. It is a corporate governance/management update regarding a board committee change, which falls under Board/Management Information (MANG).
2026-05-26 English
Pursuant to Regulation 30 of (read with Part A of Schedule III) and other applicable provisions SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ("Listing Regulations"), ....
Board/Management Information Classification · 92% confidence The document is a formal announcement to stock exchanges under SEBI Listing Regulations detailing outcomes of a Board Meeting held on 25th May 2026. It lists re-appointments of statutory, cost, and internal auditors, and the re-appointment of executive and non-executive directors. This clearly constitutes a Board/Management Information filing (changes and approvals made by the Board), matching our MANG category.
2026-05-25 English
Pursuant to regulation 30 (read with Part A Schedule III) and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), ....
Board/Management Information Classification · 90% confidence The document is an announcement of the outcome of a Board of Directors meeting under SEBI Listing Regulations. It details the re-appointment of statutory, cost, and internal auditors and, more importantly, the re-appointment of the Whole-Time Director, Managing Director, and Non-Executive Independent Directors. This is a corporate announcement concerning changes in the board and senior management, which falls under Board/Management Information (MANG).
2026-05-25 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.